Literature DB >> 2102678

A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Y Goto1, I Nonaka, S Horai.   

Abstract

Mitochondrial encephalomyopathies are usually divided into three distinct clinical subgroups: (1) mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS); (2) myoclonus epilepsy associated with ragged-red fibres (MERRF); and (3) chronic progressive external ophthalmoplegia (CPEO) including Kearns-Sayre syndrome. Large deletions of human mitochondrial DNA and a transition mutation at the mitochondrial transfer RNALys gene give rise to CPEO including Kearns-Sayre syndrome and MERRF, respectively. Here we report an A-to-G transition mutation at nucleotide pair 3,243 in the dihydrouridine loop of mitochondrial tRNA(Leu)(UUR) that is specific to patients with MELAS. Because this mutation creates an ApaI restriction site, we could perform a simple molecular diagnostic test for the disease. The mutation was present in 26 out of 31 independent MELAS patients and 1 out of 29 CPEO patients, but absent in the 5 MERRF and 50 controls tested. Southern blot analysis confirmed that the mutant DNA always coexists with the wild-type DNA (heteroplasmy).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2102678     DOI: 10.1038/348651a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  460 in total

1.  Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1.

Authors:  C Hardy; F Khanim; R Torres; M Scott-Brown; A Seller; J Poulton; D Collier; J Kirk; M Polymeropoulos; F Latif; T Barrett
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

Review 2.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

3.  Utility of multimodal evoked potential study and electroencephalography in mitochondrial encephalomyopathy.

Authors:  V Scaioli; C Antozzi; F Villani; M Rimoldi; M Zeviani; F Panzica; G Avanzini
Journal:  Ital J Neurol Sci       Date:  1998-10

4.  Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy.

Authors:  Ali Yilmaz; Hans-Jürgen Gdynia; Matthias Ponfick; Sabine Rösch; Alfred Lindner; Albert C Ludolph; Udo Sechtem
Journal:  Clin Res Cardiol       Date:  2011-12-06       Impact factor: 5.460

5.  Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Authors:  Akira Sudo; Shiho Honzawa; Ikuya Nonaka; Yu-Ichi Goto
Journal:  J Hum Genet       Date:  2004-01-17       Impact factor: 3.172

6.  Detection of the A to G(3243) mutation of mitochondrial DNA in Japanese families with mitochondrial encephalomyopathies.

Authors:  K Inui; H Tsukamoto; H Fukushima; M Taniike; J Tanaka; T Nishigaki; S Okada
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

7.  Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy.

Authors:  M Yoneda; A Chomyn; A Martinuzzi; O Hurko; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases.

Authors:  P Seibel; J Trappe; G Villani; T Klopstock; S Papa; H Reichmann
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

9.  New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters.

Authors:  Carl D Gajewski; Lichuan Yang; Eric A Schon; Giovanni Manfredi
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

10.  Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.

Authors:  S Manouvrier; A Rötig; G Hannebique; J D Gheerbrandt; G Royer-Legrain; A Munnich; M Parent; J P Grünfeld; C Largilliere; A Lombes
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.